Pharmafile Logo
Pharmafocus logo
Advanced Search
BMS image

BMS in $1.5 billion immuno-oncology expansion

February 24, 2015
Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Rigel, flexus, immuno-oncology

Bristol-Myers Squibb has confirmed two major deals to enhance the company’s standing in the immuno-oncology field. The first agreement sees …

News

WuXi PharmaTech borrows to expand

February 24, 2015
Manufacturing and Production, Sales and Marketing China, NextCODE Health, WuXi PharmaTech, XenoBiotic Laboratories, philadelphia

WuXi PharmaTech has kick started a syndicated loan arrangement in order to borrow up to $165 million from a consortium …

News
ronnie_meninger

Algatech gets new chief executive and chief scientist

February 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Algatech, Ronnie Meninger, Sammy Boussiba

Israel-based biotech Algatech has confirmed the appointment of Ronnie Meninger as its chief executive, and Sammy Boussiba as chief scientist. Meninger (pictured) …

Appointment
Merck image

Merck invests $450m in NGM Biopharma

February 23, 2015
Sales and Marketing Merck, NGM Biopharma, NP201, diabetes, nonalcoholic steatohepatitis, obesity

Merck is to collaborate on drug development with biotech firm NGM Pharmaceuticals in a $450 million deal. The collaboration will …

News
Pfizer image

Priority review for Pfizer’s lung drug

February 23, 2015
Sales and Marketing FDA, Pfizer, Rapamune, lung, lymphangioleiomyomatosis, sirolimus

The US Food and Drug Administration FDA has accepted Pfizer’s lung drug Rapamune for priority review. Rapamune (sirolimus) prevents organ …

News
Chiesi image

Chiesi’s stem cell therapy approved in Europe

February 23, 2015
Research and Development, Sales and Marketing Chiesi, EC, Europe, Holoclar, Holostem Advanced Therapies, LSCD, stem cell

Chiesi’s Holoclar has become the first stem cell therapy to get the green light in Europe, gaining conditional approval from …

News
Dementia image

UK government spends £300 million on dementia

February 23, 2015
Research and Development, Sales and Marketing Cameron, England, NHS, dementia, investment, research

UK prime minister David Cameron has said the government is to invest more than £300m into dementia research and that …

News
Valeant image

Valeant to buy Salix in $14.5 billion move

February 23, 2015
Sales and Marketing Deals, Heptares, Valeant, mergers, salix, sosei

Valeant has agreed a deal to acquire US-based speciality manufacturer of gastrointestinal drugs Salix in a move worth around $14.5 …

News
EU image

Act now – or risk running out of time for IDMP

February 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Eversheds, ISO, icsr, idmp, regulatory

Many people in pharma would argue that the world of regulatory compliance in the life sciences industry is already complicated …

Feature
anne_hyland

Kymab hires chief financial officer

February 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anne hyland, kymab

Cambridge-based UK antibody development firm Kymab has appointed Anne Hyland as its chief financial officer.  Hyland takes to the firm …

Appointment
Boehringer image

Boehringer’s beer breach at German congress

February 20, 2015
Medical Communications, Sales and Marketing ABPI, Boehringer, ERS, IPF, PMCPA, breach, code, munich

A complaint made by a pulmonologist against the competence of Boehringer Ingelheim speakers during a congress held in Germany last …

News
screen_shot_2015-02-20_at_14

Chair appointed for new MHRA devices committee

February 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, Peter Nightingale, deac

Dr Peter Nightingale has been appointed as chairman of the Medicines and Healthcare products Regulatory Agency’s (MHRA) newly-formed Devices Expert …

Appointment
Mosquito image

Resistance threat to malaria drug is ‘alarming’

February 20, 2015
Research and Development, Sales and Marketing Africa, Qinghaosu, artemisinin, malaria, thailand

Resistance to a group of drugs that possess the most rapid action against malaria – artemisinin, aka Qinghaosu ­– is …

News
GSK image

Official linked to GSK bribes facing prison

February 20, 2015
Sales and Marketing China, Deirdre Connelly, GSK, Jack Bailey, Novartis, bribes

A Chinese health official linked to the GSK bribery scandal has been sentenced to 19 years in prison. Huang Fenping, …

News
Olivier Brandicourt image

Sanofi confirms new chief executive

February 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Chris Viehbacher, Sanofi, praluent

Bayer chairman Olivier Brandicourt has been named as Sanofi’s new chief executive to replace Chris Viehbacher who was ejected from …

News

NICE is ‘setting prices too high’ for NHS

February 19, 2015
Sales and Marketing ABPI, NHS, NICE, QALY, costs, health, pharma

The cost threshold NICE uses when approving drugs is too high and is doing more harm than good, new research …

News
Revlimid image

Celgene gets FDA licence extension for myeloma drug

February 19, 2015
Sales and Marketing Celgene, FDA, Revlimid, lenalidomide, myeloma

The FDA has given Celgene an extended licence for its multiple myeloma drug Revlimid (lenalidomid), to include people who are …

News
screen_shot_2015-02-19_at_07

Pharming names new chief scientific officer

February 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharming, perry calais

Dutch biopharma development firm Pharming has named Dr Perry Calias as the company’s chief scientific officer.  Calias will have overall …

Appointment

UK pharma commits at least ‘one code breach a week’

February 18, 2015
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code

Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …

News
Sanofi image

Sanofi enters autoimmune diseases pact with Lead Pharma

February 18, 2015
Research and Development, Sales and Marketing Sanofi, autoimmune, biox, lead pharma, psoriasis

Sanofi is to collaborate with Dutch biotech firm Lead Pharma to develop treatments for autoimmune diseases. The companies will work …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026